Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -17.46
- Piotroski Score 4.00
- Grade Sell
- Symbol (NVTA)
- Company Invitae Corporation
- Price $0.02
- Changes Percentage (-35.59%)
- Change -$0.01
- Day Low $0.02
- Day High $0.02
- Year High $2.34
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 02/26/2024
- Fiscal Year End N/A
- Average Stock Price Target $10.00
- High Stock Price Target $17.00
- Low Stock Price Target $2.25
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$5.36
- Trailing P/E Ratio -0.003544776119403
- Forward P/E Ratio -0.003544776119403
- P/E Growth -0.003544776119403
- Net Income $-3,106,293,000
